SlideShare a Scribd company logo
1 of 101
Download to read offline
Suppository
(Dr.) Mirza Salman Baig
Assistant Professor (Pharmaceutics)
AIKTC, School of Pharmacy,New Panvel
Affiliated to University of Mumbai, INDIA
• The patient is unable to use the oral
route (inflection of GIT, nausea,
unconsciousness, post-operation,
young, old and mentally disturbed
patients).
• The drug is less suited for oral route
(causes GI side effects, insufficiently
stable at pH of GIT, susceptible to
enzymatic degradation, has first-
pass effect, with unacceptable taste)
2
• Slow and incomplete absorption.
• Inter and intra-subject variation.
• Problems with large scale production
of suppositories
• Short shelf life.
• Demanding stringent storage
conditions.
3
• Local effect:
- In case of pain, itching and haemorroids
- locally active drugs include astringents,
antiseptics, local anaesthetics,
vasoconstrictors, anti-inflammatory
compounds, soothing and protective
agents and laxatives.
• Systemic effect:
- Anti-asthmatics, anti-rheumatics and
analgesics.
4
• The rectum is about
15 to 20 cm long.
• It hooks up with the
sigmoid colon and
with the anal canal.
• It is a hollow organ
with a relatively flat
wall surface,
• It dose not have
villi
5
• The terminal 2 to
3 cm of the
rectum is called
the anal canal.
• The opening of
the anal canal to
the exterior is
called the anus.
6
• The anus is controlled by an internal
sphincter of smooth muscle and an
external sphincter of skeletal muscle.
• Under normal conditions, the rectum is
empty and filling provokes a defecation
reflex which under voluntary control.
• Rectum contains (about 2 to 3 ml)
mucous, which has a pH of 7.4 and little
buffering capacity.
7
• The rectal tissues
are drained by
the inferior,
middle and
superior
haemorrhoidal
veins, but only
the superior
vein connects
with the
hepatic-portal
system.
8
• Medicaments absorbed in the lower
part of the rectum are delivered
directly into the systemic circulation,
thus avoiding any first-pass
metabolism.
• However, it has been found that
suppositories can settle high enough in
the rectum to allow at least some drug
absorption into the superior vein.
• Thus keeping the drug in the lower part of
the rectum would be advisable.
9
• Insertion of a suppository into the rectum
results leads to the bioavailability of the
drug.
• Suppository will either dissolve in the
rectal fluid or melt on the mucous layer.
• Since the volume of rectal fluid is so small,
complete dissolution of the base require
extra water.
• Drugs in the suppository diffuse out &
absorption will be passive diffusion
10
1- Quantity of fluids available
• Very small volume under normal conditions
(3ml spread in a layer of approximately
100µm thick over the organ).
• Under non-physiological conditions the
volume is enlarged.
• Thus, absorption of slightly soluble drugs (i.e.
phenytoin) will be dissolution rate limited.
11
2- Properties of rectal fluids
– Composition, viscosity, pH and surface
tension of rectal fluids have great
effects on drug bioavailability.
3- Contents of the rectum
– Faecal content
12
4- Motility of the rectum
• The rectal wall may exert a pressure on a
suppository present in the lumen by two distinct
mechanisms.
• First, the abdominal organs may simply press
on to the rectum when the body in upright
position. This may stimulate spreading and promote
absorption.
• Second, the motility of the rectal muscle
associated with the presence of food in the colon
(waves of contractions running over the wall of the
colon)
13
1- Lipid-water solubility of the drug
2- Particle size of the drug
3- degree of drug ionization
4- Nature of the base
Physicochemical factors of
the drug and the base:
14
Physicochemical properties of
Suppositories Base
&
Formulation concideration
for
rectal absorption of
medicament from
suppositories
• The lipid water partition coefficient of the
drug is an important consideration in the
selection of the suppository base and in
anticipating drug release from that base.
• A lipophilic drug that is distributed in a
fatty suppository base in low
concentration has less of a tendency to
escape to the surrounding aqueous fluids
than a hydrophilic drug in its saturation
concentrations.
16
• Water-soluble bases dissolve in
rectal fluids and release both water-
soluble and oil-soluble drugs.
• The more drug in the base, the more
dug will be available for potential
absorption
• A drug with a high partition
coefficient is likely to be absorbed
more readily from a water soluble
bases.
17
Contd...Contd...
• Absorption through rectal mucosa
proceeds in accordance with pH-
partition theory.
• At the slightly alkaline pH of rectal
mucosa, weakly basic drugs will exist
in their lipid– soluble unionized form
and readily absorbed.
18
• For drugs present in the suppository
in the un-dissolved form, the size will
influence the amount released and
dissolved for absorption.
• The smaller the size, the more
readily the dissolution of the particle
and the greater the chance for rapid
absorption.
19
• If the base interacts with the drug
inhibiting its release, drug absorption
will be impaired or even prevented.
• If the base is irritating to the
mucous membranes of the rectum, it
may initiate a colonic response and
prompt a bowel movement, negating
the prospect of thorough drug
release and absorption.
20
Suppositories
A suppository is a medicated solid dosage
form generally intended for use in body
cavaties like rectum, vagina and to a
lesser extent, the urethra.
After insertion they melt or soften at
body temperature, whereas vaginal
suppositories sometimes called as
pessaries, are made to disintegrate in
body fluids.
• The medicament is incorporated into a base
such as cocoa butter which melts at body
temperature, or into glycerinated gelatin
or PEG which slowly dissolves in the mucous
secretions.
• Suppositories are suited particularly for
producing local action, or systemic effect
or to exert a mechanical effect to facilitate
emptying the lower bowel.
22
Sizes of suppositories
0 For Children
1,2 & 3 For rectal use
4 Pessaries
A & B Nasal &
urethral
bougies
• As with the ointment bases, suppository base
composition plays an important role in both the
rate and extent of release of medications.
• Suppository bases may be classified according to
their composition and physical properties:
1- Oleaginous (fatty) bases
Ex. Cocabutter (Theobroma)
2- Water soluble or miscible bases
Ex. Glycero-Gelatin base
/PEG
24
1- Origin and chemical
composition
v The source of origin (i.e. entirely
natural or synthetic or modified
natural).
v Physical and chemical
incompatibilities with additives
(i.e. preservatives, antioxidants
and emulsifiers)
25
2- Melting range
v Since fats do not have sharp
melting point, their melting
characteristics are expressed as a
range indicating the temperature
at which the fat start to melt and
the temperature at which it is
completely melted.
v Softening point. 26
3- Solidi Fat Index (SFI)
v Graph isplotted between
%solid vs temperature
v Base with sharp drop of
curve is brittle.
v This require reduced
temperature differential
between mould and base.
v SFI is determined by
dilatometry.
27
4- Hydroxyl value
v This value give quantity of momo and
diglycerides present in oleogeneous base.
v Miligram of KOH required to nutralize
unreacted acetic acid.
28
5- Solidification point
v This value indicates the time required for
base solidification when it is chilled in the
mold.
v If the interval between the melting range
and solidification point is 10ºC or more,
the time required for solidification
may have to be shortened for a more
efficient manufacturing procedure by
augmenting (increasing) refrigeration.
29
6- Saponification value
v The number of milligrams of
potassium hydroxide required to
neutralize the free fatty acids
and to saponify the esters contained
in 1 gm of fat
v It is an indication of the type of
glyceride (mono- or tri-) as well as
the amount of glyceride present.
30
7- Iodine value
v This value express the number
of grams of iodine that react with
100 gm of fat or other
unsaturated material.
v The possibility of decomposition
by moisture, acids, and oxygen
(leads to rancidity in fats)
increases with high iodine values.
31
8- Water number
v The amount of water in grams,
which can be incorporated in 100
gm of fat is expressed by this
value.
v The water number can be
increased by addition of surface
active agents.
32
9- Acid value
v The number of milligrams of KOH required
to neutralize the free acid in 1 gm of
substance is expressed by this value.
v Low acid values or complete absence
of acid are important for good
suppository bases.
v Free acids complicate formulation work,
because they react with other ingredients
and can also cause irritation when in
contact with mucous membranes.
33
Ideal Suppository Base
The ideal suppository base should be
• Nontoxic and nonirritating to sensitive and
inflamed tissues.
• Non sensitizing (allergic)
• Inert and compatible with a broad variety of
medicaments.
• Can be easily manufactured by compression or
molding.
• It has no meta-stable forms.
• Dissolve or disintegrate in the presence of mucous
secretions or melt at body temperature ( 360 C) to
allow for the release of the medication.
35
Ideal Suppository Base
Ideal Suppository Base
• Remain molten for a sufficient period of
time to allow pouring into moulds.
• Solidify sufficiently rapidly to minimize
sedimentation of dispersed solids.
• Shrink on cooling to allow easy
withdrawal of the suppository from the
mould.
• Has wetting and emulsifying properties.
• High water number.
• Stable on storage, does not change color,
odor and drug release pattern.
If the base is fatty, it has the
following additional requirements:
• Acid value is below 0.2.
• Saponification value ranges from 200
to 245.
• Iodine value is less than 7.
• The interval between melting point
and solidification point is small.
37
Include:
•Theobroma Oil
•Synthetic
triglyceride
mixtures.
38
v Theobroma Oil or cocoa butter is used as a
suppository base because, in large measure, it
fulfills the requirements of an ideal base.
v Cocoa butter is primarily a tri-glyceride (Oleopal
mitostearin) , it is yellowish- white, solid, brittle
fat, which smells and tastes like chocolate.
v At ordinary room temperatures of 15° to 25°C it
is a hard, amorphous solid,
v It melt at 30° to 35°C i.e., at body temperature,
it melts to a bland, nonirritating oil.
39
v Thus in warm climates, theobroma
oil suppositories should be
refrigerated.
v Cocoa butter has iodine value
between 34 and 38.
v Its acid value not higher than 4.
40
q Shrinks only slightly on solidification; a mould
lubricant is therefore required.
q Exists in four polymorphic forms with different
melting points
q Alfa 24
q Beta' 28-31
q Beta (stable) 34-35 (beta' sloly changes to beta
stable)
q Gamma 18
q Theobroma should only be heated for a short time
and at temperatures just below 36 ºC in order to
minimize the formation of the unstable low
melting point forms.
41
q Theobroma oil is prone to oxidation
(due to high iodine value); this can
be partly overcome by storage in a
cool, dark place.
q Theobroma oil may vary in
consistency, odor, and color
depending on its source like other
natural products.
q The low melting point of theobroma
oil may pose storage problems in hot
climates.
42
How formation of unstable
form of polymorphs can be
avoided?
• If mass is not completly melted,
remaining crystal prevent formation
of unstable crystal.
• Seeding
• Solidified mass is tempered at
280-320 C to convert Beta'--> Beta
Stable.
• Prolonged heating and overheating
must be avoided.
Additives
• Wax/Spermaceti added to keep
melting point at 35 when drug used
is volatile which can redduce melting
point.
• Emulsifier to increase water holding
capicity.
q The change (reduction) in melting point caused
by addition of certain drugs such as volatile oils,
phenol or chloral hydrate to cocoa butter
suppositories. The remedy is to raise the melting
point back to the desired range by addition of 3%
to 5% of beeswax or spermaceti.
q Theobroma oil has a low absorptive capacity
for water, but this can be increased by adding
surfactants such as cholesterol 2%, emulsifying
wax up to 10%, polysorbates 5 to 10%, or wool
fat 5 to 10%. However, the addition of
surfactants may lead to a drug- base interaction
or affect the release of drug from suppository.
45
Additives contd...
Substitutes of cocabutter
• Synthetic triglycerides
• Palm kernel oil
• Hydrogenated corn oil
q The newer synthetic tri-glycerides consist of
esterified, hydrogenated or fractionated
vegetable oils.
q Their advantages over cocoa butter are:
1- Do not exhibit polymorphism.
2- Contain mainly saturated acids (Iodine number
<3), while cocoa butter contains considerable
amount of the unsaturated fatty acids (Iodine
number 34-38).
47
3- The melting range of the synthetic bases is
usually about 3ºC higher than that of cocoa
butter
4- The acid content is lower (mostly <0.5)
5- hard fat is a mixture of mono, di and tri-
glycerides of saturated fatty acids (C10 to
C18). The hydroxyl value of a base is
determined by the proportions of mono and
di-glycerides contained in it. A higher
hydroxyl value indicates that the base can
absorb water more readily and less suitable
to easily hydrolyzed drugs.
48
6- The solidification temperatures of hard fats are
unaffected by over heating.
7- There is only a small temperature difference
between melting and solidification, thus the
sedimentation of suspended drugs is minimized.
8- The water absorbing capacity of hard fats can
be improved (to about 25% or 30% w/w) by
inclusion of glyceryl monostearate.
49
q A tendency to fracture upon pouring into
chilled moulds can be overcome by
including very small quantities of
polysorbate 80.
q On prolonged storage, synthetic
suppository bases have been shown to
be subjected to crystallization, which
causes hardening and increases the
melting time. This can be reduced by
storage in a cold place.
50
A. Glycerinated
gelatin
B. Polyethylene
glycol (PEG)
polymers.
51
Hydrophilic suppositories base
v Glycerinated Gelatin is a useful
suppository base, particularly for vaginal
suppositories, where the prolonged
localized action is usually desired.
v Glycerinated gelatin suppositories are
translucent, resilient, gelatinous solids
that tend to dissolve in mucous
secretions to provide prolonged release
of active ingredients.
v It is suitable for use with a wide range
of medicaments including alkaloids,
boric acid, and zinc oxide.
52
v Suppositories made with glycerinated
gelatin must be kept in well-closed
containers in a cool place since they will
absorb and dissolve in atmospheric
moisture.
v Suppositories may have a dehydrating
effect and be irritating to the tissues upon
insertion.
v The water present in the formula of
suppositories minimizes this action and the
suppositories may be moistened with water
prior to insertion to reduce the tendency of
the base to draw water from mucous.
53
Contd...Contd...
• Mix or dissolve the medicaments in water
to make a total of 10 g.
• Add 70 g of glycerin and mix.
• Add 20 g of granular gelatin, mix carefully
to avoid incorporation of air.
• Heat on a steam bath until the gelatin is
dissolved.
• Pour the melted mixture into molds and
allow to congeal.
54
• The gelatin constitutes about 60% of
the weight of the formula, the
glycerin about 20%, and the
medicated aqueous portion about
20%.
55
q Polyethylene Glycol Polymers are
chemically stable, nonirritating, miscible
with water and mucous secretions, and
can be formulated, either by molding or
compression, in a wide range of hardness
and melting point.
56
q Like glycerinated gelatin, they do not melt
at body temperature, but dissolve to
provide a more prolonged release than
theobroma oil.
q Certain polyethylene glycol polymers may
be used singly as suppository bases
q Some times more molecular weights
PEG mixed in various proportions as
needed to yield a finished product of
satisfactory hardness and dissolution
time.
57
PEG Contd...PEG Contd...
q PEGs having average molecular weights of
200, 400 and 600 are clear, colorless
liquids.
q Those having molecular weights of
greater than 1000 are wax-like, white
solids with hardness increasing with an
increase in the molecular weight.
q Since the water miscible suppositories
dissolve in body fluids and need not be
formulated to melt at body
temperature, they can be formulated
with much higher melting points.
58
PEG Contd...PEG Contd...
q This property permits a slower release
of medicaments from the base, safe
storage at room temperature without need
for refrigeration, and ease and slow
insertion.
q To prevent irritation of the mucous
membranes after insertion of PEGs
suppositories, they should contain at
least 20% of water or dipped in water
just prior to use.
59
PEG Contd...PEG Contd...
14501450
80008000
300300
80008000
30%30%
70%70%
60%60%
40%40%
300300
60006000
10001000
33503350
10001000
33503350
48%48%
52%52%
95%95%
5%5%
75%75%
25%25%
60
• Chemical or physical Mixtures of oleaginous and
water soluble or water miscible materials.
• Emulsions, generally of w/o type (i.e. mixing
of cocoa butter with emulsifying agents).
• Polyoxyl 40 stearate is a mixture of the mono-
stearate and di-stearate esters of mixed poly-
oxyethylene diols and the free glycols.
• Soap may be used as a base (i.e. Glycerin
suppositories, USP, with soap as the base).
61
Suppositories can be extemporaneously
prepared by one of three methods.
1. Hand Rolling
• It is the oldest and simplest method of
suppository preparation and may be
used when only a few suppositories are
to be prepared in a cocoa butter base.
• It has the advantage of avoiding the
necessity of heating the cocoa butter.
• A plastic-like mass is prepared by
triturating grated (pulverized) cocoa
butter and active ingredients in a
mortar.
62
• The mass is formed into a ball in the palm of
the hands, then rolled into a uniform cylinder
with a large spatula or small flat board on a pill
tile.
• The cylinder is then cut into the
appropriate number of pieces which are
rolled on one end to produce a conical shape.
• Effective hand rolling requires considerable
practice and skill.
63
• Compression molding is a method of
preparing suppositories from a mixed mass
of grated suppository base and
medicaments which is forced into a
special compression mold using
suppository making machines.
• The suppository base and the other
ingredients are combined by thorough
mixing.
• The friction of the process causing the base
to soften into a past-like consistency.
64
• On large scale, mechanically operated mixers
and a warmed mixing vessels are used.
• In the compression machine, the
suppository mass is placed into a
cylinder which is then closed.
• Pressure is applied from one end to
release the mass from the other end into the
suppository mold or die.
65
Contd...Contd...
Compression molding machine
• Prepared mass C is placed
in a cylinder A
• It is forced through narrow
opening D by means of piston
B into a mould.
• Threads of mass pass in the
mould G and are compressed
until a homogenous fused
mass is formed in E.
• The mass and compression
cylinder of the machine may
be chilled to prevent heat
of compression from
making the mass too fluid.
• When the die is filled with the mass,
a movable end 'plate-F' at the back
of the die is removed
• Additional pressure is applied to eject
suppository
67
Contd...Contd...
• Fusion Molding involves:
1- Melting the suppository base
2- Dispersing or dissolving the drug in the melted
base.
3- The mixture is removed from the heat and
poured into a suppository mold.
4- Allowing the melt to congeal
5- Removing the formed suppositories from the
mold.
• The fusion method can be used with all types of
suppositories and must be used with most of them.
68
Contd...
• Small scale molds
are capable of
producing 6 or 12
suppositories in a
single operation.
• Industrial molds
produce hundreds of
suppositories from a
single molding.
70
• Depending on the formulation,
suppository molds may require
lubrication before the melt is poured to
facilitate the clean and easy removal of
the molded suppository.
• Lubrication is seldom necessary when
the suppository base is contracting
sufficiently on cooling.
• Lubrication is usually necessary when
glycerinated gelatin suppositories are
prepared.
71
Automatic moulding machine
• it can make 10000
unit/hr
Formulation concideration
• For local use / Systematic use?
• Site of application,
rectal/vaginal/urethral?
• Quick release/ prolonged release?
Suppositories for systemic effect
1. Should have sufficient absorption from particular
body cavity (if for systemic use)
2. Best suited for drugs undergoing first pass
metabolism, degrade in GI fluids or irritate the GI
mucosa
3. Should be easily dispersible or soluble in the base
4. Should be soluble to achieve homogeneity but
should not have more affinity for the base or else it
wouldn't get released
5.Particle size should be less to improve
bioavailability and decrease irritation
6. Density and solubility of the drug should ensure
minimum usage of base.
7. Drug should be compatible and stable in base and at
processing conditions
8. Water soluble drug added in oil soluble base and vice
versa
Contd...
• Suppositories for Local effect
– Nonabsorbable drug
– Nonabsorbable base
– Slow melting base
– Should melt within 4-6 hour
Problems in formulation of
suppositories
• Water in Suppositories
• Hygroscopicity
• Incompatibilities
• Viscosity
• Brittelness
• Density
• Volume contraction
• Lubrication
• Dose replacement
• Wt. and volume control
• Rancidity/antioxidant
1. Water in suppositories
Formulators do not like to use water for dissolving
drugs in suppositories for the following reasons :
a) Water causes hydrolysis of fats.
b) If the suppositories are manufactured at a high
temperature, the water evaporates, the drugs
crystallize out.
c) Absorption of water soluble drugs is enhanced only
if the base is an oil – in – water emulsion
d) And more than 50% of the water should be in
the external phase.
e) Drug excipient interactions are more likely to
happen in the presence of water.
f) Bacterial contamination may be a problem, so
we may be forced to add a preservative.
2. Hygroscopicity
• Glycerogelatin suppositories lose moisture
in dry climates and absorb moisture in
humid conditions
• The hygroscopicity of polyethylene glycol
bases depends on the chain length of the
molecule
• As the molecular weight of these ethylene
oxide polymers increases the
hygroscopicity decreases
3. Drug-excipient interactions
• Incompatibilities exist between
polyethylene glycol base and some
drugs eg. quinine.
• Sodium barbital and salicylic acid
crystallize out of polyethylene glycol.
• High concentrations of salicylic acid
soften polyethylene glycol to an
ointment like consistency.
• Penicillin G is stable in cocoa butter and
other fatty bases but decomposes in
polyethylene glycol bases.
4. Viscosity
• When the base has low viscosity,
sedimentation of the drug before
solidification is a problem.
• Well mixed mass should be handelled
at lowest possible temperature.
• 2% aluminium monostearate may
be added to increase the viscosity of
the base
• Cetyl and stearyl alcohols or stearic
acid are added to improve the
consistency of suppositories
5. Brittleness
• Cocoa butter suppositories are elastic,
not brittle
• Synthetic fat bases are brittle
• This problem can be overcome by
keeping the temperature difference
between the melted base and the
mold as small as possible
• Materials that impart plasticity to a
fat and make them less brittle are
small amounts of Tween 80, castor oil,
glycerin or propylene glycol
6. Density
• Density of the base, the drug, the
volume of the mould and whether the
base is having the property of volume
contraction are all important.
• They all determine the weight of the
suppository
7. Volume contraction
• Because of volume contraction suppositoray esily slip
away from the mould, preventing the need for a
lubricating agent.
• When the suppository mass is contracting, a hole
forms at the open end, This gives an inelegant
appearance to the suppository. Weight variation
among suppositories is also likely to occur.
• To avoid this problem of volume contraction
• Overfill the molds, and scrape off the excess mass
which contains the contraction hole
• Pour the suppository mass slightly above its
congealing temperature into a mould warmed to
about the same temperature.
Displacement value
• The displacement value is defined as the
number of gram of ingredients (or Drug) that
displace one gram of Suppository base
• The volume of suppositories from a particular mould
will be constant but the weight will vary because the
densities of the medicaments usually differ from the
density of the base, and hence the density of the
medicament will affect the amount of the base
required for each suppository
• f=[100(E-G)/GX]+1
f=replacement factor
E= wt of pure base suppository
G= wt of suppository withh X% of drug
Example 1
If a prescription requires 400 mg of bismuth subgallate per suppository weighing two
grams, what would be the displacement value if it is known that six suppositories
with required bismuth subgallate weigh 13.6 g?
Theoretical weight of six cocoa butter suppositories without bismuth subgallate = 12 g
Given weight of six cocoa butter suppositories with bismuth subgallate =13.6 g
Wt. of bismuth subgallate in the six suppositories = 0.4 × 6 = 2.4 g
Wt. of cocoa butter in the bismuth subgallate suppositories = 13.6 − 2.4 = 11.2 g
Cocoa butter displaced by 2.4 g of bismuth subgallate = 12 − 11.2 = 0.8
The displacement value of bismuth subgallate is 2.4/0.8 = 3
Example 2
• If 12 cocoa butter suppositories containing 40% zinc oxide weigh
17.6 grams,what is the displacement value of zinc oxide? Assume
that the suppositories are made in a 1-g mold
• Given weight of 12 suppositories with zinc oxide = 17.6 grams
• Weight of zinc oxide in the suppositories
= (40/100) × 17.6 = 7.04 g
• Weight of cocoa butter in the suppositories
= (60/100) × 17.6 = 10.56 g
• Theoretical weight of 12 suppositories without zinc oxide = 12 g
• Cocoa butter displaced by 7.04 g of zinc oxide
= 12 − 10.56 = 1.44
• Displacement value of zinc oxide
= (7.04/1.44) = 4.89
9. Weight and volume control
Various factors influence the weight of the
suppository, the volume of the suppository and
the amount of active ingredient in each
suppository are--
1. Concentration of the drug in the mass
2. Volume of the mould cavity
3. The specific gravity of the base
4. Volume variation between moulds
5. Weight variation between suppositories due to
the inconsistencies in the manufacturing
process, The limit for the weight variation in
suppositories is 5%.
10. Lubrication of moulds
• Some widely used lubricating agents
are mineral oil, aqueous solution of
SLS, alcohol and tincture of green
soap. These are applied by wiping,
brushing or spraying
11. Rancidity
• The unsaturated fatty acids in the
suppository bases undergo
autooxidation and decompose into
aldehydes, ketones and acids. These
products have strong, unpleasant
odours
• The lower the content of
unsaturated fatty acids in a base,
the higher is its resistance to rancidity
EVALUATION OF SUPPOSITORIES
Finished suppositories are routinely
inspected for; appearance & content
uniformity beside this--
• Melting range test/micromelting range
• Softning time (U tube water bath &
glass rod)
• Drug release test
• Breaking test (Fragility test)
• Disintegration test
• Macro-melting range is a measure of
the time it takes for the entire
suppository to melt when immersed
in a constant-temperature (37ºC)
water bath.USP tablet disintegration
apparatus is used
• Micromelting range for fat base using
capilllary tubes
• ERWEKA® apparatus consist spiral
tube with thermostat water jacket.
91
Softening time
• In this test a U tube is partially immersed in a
constant temperature bath and is maintained at a
temperature between 35 to 37°C.
• There is a constriction in the tube in which the
suppository is kept
• and above the suppository, a glass rod is kept.
• The time taken for the glass rod to go
through the suppository and reach the
constriction is known as or softening time.
• Another apparatus is there for finding “softening
time” which mimics in vivo conditions.
• It uses a cellophane tube, and the temperature is
maintained by water circulation. Time taken for
the suppository to melt is noted
Breaking test
• To measure the fragility or
brittleness of suppository
• Double wall chamber in which the
test suppository is placed.
• Water at 37ºC is pumped through
the double wall.
• The suppository supports a disc to
which rod is attached.
• The other end of the rod consist of
another disc to which weights are
applied.
94
• The test was conducted by placing the
suppository to support the axis of 600 g
weight.
• At one minute intervals 200 gm weights
are added.
• The weight at which the suppository
collapses is the breaking point
• Different shape suppositories have
different value of hardness.
95
Breaking test
Dissolution/Disintegration test
• In-vitro drug release pattern is measured by
using ERWEKA® Disintegration
apparatus
• Aliquots of the release medium were taken
at different time intervals within the melting
period.
• The drug content in the aliquots was
determined using UV
• The drug release pattern was plotted (time
versus-drug release curve)
Dissolution test apparatus
Packaging
• Aluminium foil
• Paper wrap
• in-package moulding
Packaging of suppositories
• They should not touch each other, otherwise they
may fuse togther
• Proper wrapinng with aluminium foil, or paper is
required
• Machine packaging avoid nonuniformity
– after solidification wraping
– sealing using two halves of plastic
• In package moulding
– Top of package mould remain open, after mass injected it
is sealed
– High production rate
– At high temperature shape is retained
Packaging, labelling & Storage for suppositories
Rigid paperboard
boxes
Flat box with a lid
Labelling :
1. Store in a cool place
2. For rectal use only
3. Moisten before use (for glycero-gelatin and
macrogol bases)
Thank You

More Related Content

What's hot (20)

Gels
GelsGels
Gels
 
Disperse systems
Disperse systemsDisperse systems
Disperse systems
 
Suppository
SuppositorySuppository
Suppository
 
Emulsion
EmulsionEmulsion
Emulsion
 
Ointment
OintmentOintment
Ointment
 
Liquid Dosage Form
Liquid Dosage FormLiquid Dosage Form
Liquid Dosage Form
 
semisolid dosage form-1
semisolid dosage form-1semisolid dosage form-1
semisolid dosage form-1
 
Emulsion stability
Emulsion stabilityEmulsion stability
Emulsion stability
 
Emulsions
EmulsionsEmulsions
Emulsions
 
Surfactants and their applications in pharmaceutical dosage form
Surfactants and their applications in pharmaceutical dosage formSurfactants and their applications in pharmaceutical dosage form
Surfactants and their applications in pharmaceutical dosage form
 
HLB SCALE
HLB SCALE HLB SCALE
HLB SCALE
 
emulsion
emulsionemulsion
emulsion
 
Physical Pharmaceutics-I Unit-III Surface and Interfacial tension (Part-1)(Li...
Physical Pharmaceutics-IUnit-IIISurface and Interfacial tension (Part-1)(Li...Physical Pharmaceutics-IUnit-IIISurface and Interfacial tension (Part-1)(Li...
Physical Pharmaceutics-I Unit-III Surface and Interfacial tension (Part-1)(Li...
 
Preformulation studies for bulk characterization
Preformulation studies for bulk characterizationPreformulation studies for bulk characterization
Preformulation studies for bulk characterization
 
Semisolid dosage forms: Paste and Jellies
Semisolid dosage forms: Paste and JelliesSemisolid dosage forms: Paste and Jellies
Semisolid dosage forms: Paste and Jellies
 
Surface and interfacial phenomenon
Surface and interfacial  phenomenonSurface and interfacial  phenomenon
Surface and interfacial phenomenon
 
Gels & jellies
Gels & jelliesGels & jellies
Gels & jellies
 
Pharmaceutical suspension
Pharmaceutical suspension Pharmaceutical suspension
Pharmaceutical suspension
 
Cream
CreamCream
Cream
 
Liquid dosage forms
Liquid dosage formsLiquid dosage forms
Liquid dosage forms
 

Viewers also liked

Pharmaceutical suppositories
Pharmaceutical suppositoriesPharmaceutical suppositories
Pharmaceutical suppositoriesJabir Jabir
 
Cocoa butter based suppository formulation
Cocoa butter based suppository formulationCocoa butter based suppository formulation
Cocoa butter based suppository formulationjimmmcelroy510
 
P R E P A R A T I O N O F S U P P O S I T O R I E S
P R E P A R A T I O N  O F  S U P P O S I T O R I E SP R E P A R A T I O N  O F  S U P P O S I T O R I E S
P R E P A R A T I O N O F S U P P O S I T O R I E Saldebaran4
 
Suppository formulation overview
Suppository formulation overviewSuppository formulation overview
Suppository formulation overviewJim McElroy
 
Good laboratory practice SOP
Good laboratory practice SOPGood laboratory practice SOP
Good laboratory practice SOPPostgradoMLCC
 
Individualization of Patient Treatment
Individualization of Patient TreatmentIndividualization of Patient Treatment
Individualization of Patient TreatmentSandro Esteves
 
Pharmacy SOP Standard Operating Procedures | Pharmacy SOP
Pharmacy SOP Standard Operating Procedures | Pharmacy SOPPharmacy SOP Standard Operating Procedures | Pharmacy SOP
Pharmacy SOP Standard Operating Procedures | Pharmacy SOPthomusrose
 
Progesterone for luteal phase support in IVF cycles
 Progesterone for luteal phase support in IVF  cycles Progesterone for luteal phase support in IVF  cycles
Progesterone for luteal phase support in IVF cyclesHesham Al-Inany
 

Viewers also liked (20)

Pharmaceutical suppositories
Pharmaceutical suppositoriesPharmaceutical suppositories
Pharmaceutical suppositories
 
Cocoa butter based suppository formulation
Cocoa butter based suppository formulationCocoa butter based suppository formulation
Cocoa butter based suppository formulation
 
Suppository
SuppositorySuppository
Suppository
 
Suppositories
SuppositoriesSuppositories
Suppositories
 
Ch.12 suppositories
Ch.12   suppositoriesCh.12   suppositories
Ch.12 suppositories
 
P R E P A R A T I O N O F S U P P O S I T O R I E S
P R E P A R A T I O N  O F  S U P P O S I T O R I E SP R E P A R A T I O N  O F  S U P P O S I T O R I E S
P R E P A R A T I O N O F S U P P O S I T O R I E S
 
Suppositories
SuppositoriesSuppositories
Suppositories
 
Suppository
SuppositorySuppository
Suppository
 
Tablets and Suppositories
Tablets and SuppositoriesTablets and Suppositories
Tablets and Suppositories
 
Suppository formulation overview
Suppository formulation overviewSuppository formulation overview
Suppository formulation overview
 
Sop For Hemoglobin Estimation
Sop For Hemoglobin EstimationSop For Hemoglobin Estimation
Sop For Hemoglobin Estimation
 
Good laboratory practice SOP
Good laboratory practice SOPGood laboratory practice SOP
Good laboratory practice SOP
 
Counseling
CounselingCounseling
Counseling
 
Preparations of suppository
Preparations of suppositoryPreparations of suppository
Preparations of suppository
 
Individualization of Patient Treatment
Individualization of Patient TreatmentIndividualization of Patient Treatment
Individualization of Patient Treatment
 
Catgut
CatgutCatgut
Catgut
 
Pharmacy SOP Standard Operating Procedures | Pharmacy SOP
Pharmacy SOP Standard Operating Procedures | Pharmacy SOPPharmacy SOP Standard Operating Procedures | Pharmacy SOP
Pharmacy SOP Standard Operating Procedures | Pharmacy SOP
 
Suppositories
SuppositoriesSuppositories
Suppositories
 
Rectal preps
Rectal prepsRectal preps
Rectal preps
 
Progesterone for luteal phase support in IVF cycles
 Progesterone for luteal phase support in IVF  cycles Progesterone for luteal phase support in IVF  cycles
Progesterone for luteal phase support in IVF cycles
 

Similar to Suppositories sb

Suppositories and pessaries
Suppositories and pessariesSuppositories and pessaries
Suppositories and pessariesNabina Paudel
 
SUPPOSITORIES & PESSARIES Pharmaceutics .ppt
SUPPOSITORIES & PESSARIES Pharmaceutics .pptSUPPOSITORIES & PESSARIES Pharmaceutics .ppt
SUPPOSITORIES & PESSARIES Pharmaceutics .pptnsppharmacist
 
Suppository - Types & Formulation
Suppository - Types & FormulationSuppository - Types & Formulation
Suppository - Types & FormulationZobayer Hossain
 
suppositories Dr.pptx
suppositories Dr.pptxsuppositories Dr.pptx
suppositories Dr.pptxDr. Samia
 
SMEDDS- Self Micro Emulsifying Drug Delivery System.pptx
SMEDDS- Self Micro Emulsifying Drug Delivery System.pptxSMEDDS- Self Micro Emulsifying Drug Delivery System.pptx
SMEDDS- Self Micro Emulsifying Drug Delivery System.pptxTanmai25
 
gastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approachesgastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approachesmangasrinivas37
 
Rectal Drug Delivery Systems
Rectal Drug Delivery SystemsRectal Drug Delivery Systems
Rectal Drug Delivery SystemsPrayasAcharya1
 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspensionkaleab taye
 
Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics
Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics
Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics gopu vijaya sindhuri
 
Buccal Drug Delivery System
Buccal Drug Delivery SystemBuccal Drug Delivery System
Buccal Drug Delivery SystemMOHAMMAD ASIM
 
Rectal drug delivery systems
Rectal drug delivery systemsRectal drug delivery systems
Rectal drug delivery systemschiranjibi68
 
Factors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxFactors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxGirijaSoori
 

Similar to Suppositories sb (20)

SUPPOSITORIES.pdf
SUPPOSITORIES.pdfSUPPOSITORIES.pdf
SUPPOSITORIES.pdf
 
Suppositories and pessaries
Suppositories and pessariesSuppositories and pessaries
Suppositories and pessaries
 
SUPPOSITORIES & PESSARIES Pharmaceutics .ppt
SUPPOSITORIES & PESSARIES Pharmaceutics .pptSUPPOSITORIES & PESSARIES Pharmaceutics .ppt
SUPPOSITORIES & PESSARIES Pharmaceutics .ppt
 
Suppositories SB 2020
Suppositories SB 2020Suppositories SB 2020
Suppositories SB 2020
 
Suppository - Types & Formulation
Suppository - Types & FormulationSuppository - Types & Formulation
Suppository - Types & Formulation
 
suppositories Dr.pptx
suppositories Dr.pptxsuppositories Dr.pptx
suppositories Dr.pptx
 
Suppository
SuppositorySuppository
Suppository
 
SMEDDS- Self Micro Emulsifying Drug Delivery System.pptx
SMEDDS- Self Micro Emulsifying Drug Delivery System.pptxSMEDDS- Self Micro Emulsifying Drug Delivery System.pptx
SMEDDS- Self Micro Emulsifying Drug Delivery System.pptx
 
gastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approachesgastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approaches
 
Gastrorentive drug delivery systems
Gastrorentive drug delivery systemsGastrorentive drug delivery systems
Gastrorentive drug delivery systems
 
Rectal Drug Delivery Systems
Rectal Drug Delivery SystemsRectal Drug Delivery Systems
Rectal Drug Delivery Systems
 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspension
 
Suppository
SuppositorySuppository
Suppository
 
Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics
Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics
Suppositories by G VIJAYA SINDHURI(Ph.D) Department of pharmaceutics
 
Mouth Dissolving Film
Mouth Dissolving FilmMouth Dissolving Film
Mouth Dissolving Film
 
Factors affecting absorption
Factors affecting absorptionFactors affecting absorption
Factors affecting absorption
 
Rectal &amp; vaginal
Rectal &amp; vaginalRectal &amp; vaginal
Rectal &amp; vaginal
 
Buccal Drug Delivery System
Buccal Drug Delivery SystemBuccal Drug Delivery System
Buccal Drug Delivery System
 
Rectal drug delivery systems
Rectal drug delivery systemsRectal drug delivery systems
Rectal drug delivery systems
 
Factors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxFactors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptx
 

More from Mirza Salman Baig

More from Mirza Salman Baig (20)

Suspension sb pci
Suspension sb pciSuspension sb pci
Suspension sb pci
 
F.y.b. pharm syllbus
F.y.b. pharm syllbusF.y.b. pharm syllbus
F.y.b. pharm syllbus
 
Interfacial Phenomenon SB
Interfacial Phenomenon SBInterfacial Phenomenon SB
Interfacial Phenomenon SB
 
Buffer: Applications and capacity SB
Buffer: Applications and capacity SBBuffer: Applications and capacity SB
Buffer: Applications and capacity SB
 
Sorensen's pH scale SB
Sorensen's pH scale SBSorensen's pH scale SB
Sorensen's pH scale SB
 
Cosmetics SB 2020
Cosmetics SB 2020Cosmetics SB 2020
Cosmetics SB 2020
 
Semisolids sb 2020
Semisolids sb 2020Semisolids sb 2020
Semisolids sb 2020
 
States of Matter SB
States of Matter SBStates of Matter SB
States of Matter SB
 
Biphasic systems suspension sb
Biphasic systems suspension sbBiphasic systems suspension sb
Biphasic systems suspension sb
 
Large scale manufacture of suspension emulsion sb
Large scale manufacture of suspension emulsion sbLarge scale manufacture of suspension emulsion sb
Large scale manufacture of suspension emulsion sb
 
Introduction biphasic system suspension emulsion
Introduction biphasic system suspension emulsionIntroduction biphasic system suspension emulsion
Introduction biphasic system suspension emulsion
 
Solubility of drugs
Solubility of drugsSolubility of drugs
Solubility of drugs
 
Dissolution v2
Dissolution v2Dissolution v2
Dissolution v2
 
Diffusion v2
Diffusion v2Diffusion v2
Diffusion v2
 
Accelerated stability testing v2
Accelerated stability testing v2Accelerated stability testing v2
Accelerated stability testing v2
 
Chemical kinetics v2
Chemical kinetics v2Chemical kinetics v2
Chemical kinetics v2
 
Buffer and Buffer capacity
Buffer and Buffer capacityBuffer and Buffer capacity
Buffer and Buffer capacity
 
Buffer and Buffer capacity
Buffer and Buffer capacityBuffer and Buffer capacity
Buffer and Buffer capacity
 
Interfacial Phenomena
Interfacial PhenomenaInterfacial Phenomena
Interfacial Phenomena
 
Solid state
Solid stateSolid state
Solid state
 

Recently uploaded

Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 

Recently uploaded (20)

Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 

Suppositories sb

  • 1. Suppository (Dr.) Mirza Salman Baig Assistant Professor (Pharmaceutics) AIKTC, School of Pharmacy,New Panvel Affiliated to University of Mumbai, INDIA
  • 2. • The patient is unable to use the oral route (inflection of GIT, nausea, unconsciousness, post-operation, young, old and mentally disturbed patients). • The drug is less suited for oral route (causes GI side effects, insufficiently stable at pH of GIT, susceptible to enzymatic degradation, has first- pass effect, with unacceptable taste) 2
  • 3. • Slow and incomplete absorption. • Inter and intra-subject variation. • Problems with large scale production of suppositories • Short shelf life. • Demanding stringent storage conditions. 3
  • 4. • Local effect: - In case of pain, itching and haemorroids - locally active drugs include astringents, antiseptics, local anaesthetics, vasoconstrictors, anti-inflammatory compounds, soothing and protective agents and laxatives. • Systemic effect: - Anti-asthmatics, anti-rheumatics and analgesics. 4
  • 5. • The rectum is about 15 to 20 cm long. • It hooks up with the sigmoid colon and with the anal canal. • It is a hollow organ with a relatively flat wall surface, • It dose not have villi 5
  • 6. • The terminal 2 to 3 cm of the rectum is called the anal canal. • The opening of the anal canal to the exterior is called the anus. 6
  • 7. • The anus is controlled by an internal sphincter of smooth muscle and an external sphincter of skeletal muscle. • Under normal conditions, the rectum is empty and filling provokes a defecation reflex which under voluntary control. • Rectum contains (about 2 to 3 ml) mucous, which has a pH of 7.4 and little buffering capacity. 7
  • 8. • The rectal tissues are drained by the inferior, middle and superior haemorrhoidal veins, but only the superior vein connects with the hepatic-portal system. 8
  • 9. • Medicaments absorbed in the lower part of the rectum are delivered directly into the systemic circulation, thus avoiding any first-pass metabolism. • However, it has been found that suppositories can settle high enough in the rectum to allow at least some drug absorption into the superior vein. • Thus keeping the drug in the lower part of the rectum would be advisable. 9
  • 10. • Insertion of a suppository into the rectum results leads to the bioavailability of the drug. • Suppository will either dissolve in the rectal fluid or melt on the mucous layer. • Since the volume of rectal fluid is so small, complete dissolution of the base require extra water. • Drugs in the suppository diffuse out & absorption will be passive diffusion 10
  • 11. 1- Quantity of fluids available • Very small volume under normal conditions (3ml spread in a layer of approximately 100µm thick over the organ). • Under non-physiological conditions the volume is enlarged. • Thus, absorption of slightly soluble drugs (i.e. phenytoin) will be dissolution rate limited. 11
  • 12. 2- Properties of rectal fluids – Composition, viscosity, pH and surface tension of rectal fluids have great effects on drug bioavailability. 3- Contents of the rectum – Faecal content 12
  • 13. 4- Motility of the rectum • The rectal wall may exert a pressure on a suppository present in the lumen by two distinct mechanisms. • First, the abdominal organs may simply press on to the rectum when the body in upright position. This may stimulate spreading and promote absorption. • Second, the motility of the rectal muscle associated with the presence of food in the colon (waves of contractions running over the wall of the colon) 13
  • 14. 1- Lipid-water solubility of the drug 2- Particle size of the drug 3- degree of drug ionization 4- Nature of the base Physicochemical factors of the drug and the base: 14
  • 15. Physicochemical properties of Suppositories Base & Formulation concideration for rectal absorption of medicament from suppositories
  • 16. • The lipid water partition coefficient of the drug is an important consideration in the selection of the suppository base and in anticipating drug release from that base. • A lipophilic drug that is distributed in a fatty suppository base in low concentration has less of a tendency to escape to the surrounding aqueous fluids than a hydrophilic drug in its saturation concentrations. 16
  • 17. • Water-soluble bases dissolve in rectal fluids and release both water- soluble and oil-soluble drugs. • The more drug in the base, the more dug will be available for potential absorption • A drug with a high partition coefficient is likely to be absorbed more readily from a water soluble bases. 17 Contd...Contd...
  • 18. • Absorption through rectal mucosa proceeds in accordance with pH- partition theory. • At the slightly alkaline pH of rectal mucosa, weakly basic drugs will exist in their lipid– soluble unionized form and readily absorbed. 18
  • 19. • For drugs present in the suppository in the un-dissolved form, the size will influence the amount released and dissolved for absorption. • The smaller the size, the more readily the dissolution of the particle and the greater the chance for rapid absorption. 19
  • 20. • If the base interacts with the drug inhibiting its release, drug absorption will be impaired or even prevented. • If the base is irritating to the mucous membranes of the rectum, it may initiate a colonic response and prompt a bowel movement, negating the prospect of thorough drug release and absorption. 20
  • 21. Suppositories A suppository is a medicated solid dosage form generally intended for use in body cavaties like rectum, vagina and to a lesser extent, the urethra. After insertion they melt or soften at body temperature, whereas vaginal suppositories sometimes called as pessaries, are made to disintegrate in body fluids.
  • 22. • The medicament is incorporated into a base such as cocoa butter which melts at body temperature, or into glycerinated gelatin or PEG which slowly dissolves in the mucous secretions. • Suppositories are suited particularly for producing local action, or systemic effect or to exert a mechanical effect to facilitate emptying the lower bowel. 22
  • 23. Sizes of suppositories 0 For Children 1,2 & 3 For rectal use 4 Pessaries A & B Nasal & urethral bougies
  • 24. • As with the ointment bases, suppository base composition plays an important role in both the rate and extent of release of medications. • Suppository bases may be classified according to their composition and physical properties: 1- Oleaginous (fatty) bases Ex. Cocabutter (Theobroma) 2- Water soluble or miscible bases Ex. Glycero-Gelatin base /PEG 24
  • 25. 1- Origin and chemical composition v The source of origin (i.e. entirely natural or synthetic or modified natural). v Physical and chemical incompatibilities with additives (i.e. preservatives, antioxidants and emulsifiers) 25
  • 26. 2- Melting range v Since fats do not have sharp melting point, their melting characteristics are expressed as a range indicating the temperature at which the fat start to melt and the temperature at which it is completely melted. v Softening point. 26
  • 27. 3- Solidi Fat Index (SFI) v Graph isplotted between %solid vs temperature v Base with sharp drop of curve is brittle. v This require reduced temperature differential between mould and base. v SFI is determined by dilatometry. 27
  • 28. 4- Hydroxyl value v This value give quantity of momo and diglycerides present in oleogeneous base. v Miligram of KOH required to nutralize unreacted acetic acid. 28
  • 29. 5- Solidification point v This value indicates the time required for base solidification when it is chilled in the mold. v If the interval between the melting range and solidification point is 10ºC or more, the time required for solidification may have to be shortened for a more efficient manufacturing procedure by augmenting (increasing) refrigeration. 29
  • 30. 6- Saponification value v The number of milligrams of potassium hydroxide required to neutralize the free fatty acids and to saponify the esters contained in 1 gm of fat v It is an indication of the type of glyceride (mono- or tri-) as well as the amount of glyceride present. 30
  • 31. 7- Iodine value v This value express the number of grams of iodine that react with 100 gm of fat or other unsaturated material. v The possibility of decomposition by moisture, acids, and oxygen (leads to rancidity in fats) increases with high iodine values. 31
  • 32. 8- Water number v The amount of water in grams, which can be incorporated in 100 gm of fat is expressed by this value. v The water number can be increased by addition of surface active agents. 32
  • 33. 9- Acid value v The number of milligrams of KOH required to neutralize the free acid in 1 gm of substance is expressed by this value. v Low acid values or complete absence of acid are important for good suppository bases. v Free acids complicate formulation work, because they react with other ingredients and can also cause irritation when in contact with mucous membranes. 33
  • 35. The ideal suppository base should be • Nontoxic and nonirritating to sensitive and inflamed tissues. • Non sensitizing (allergic) • Inert and compatible with a broad variety of medicaments. • Can be easily manufactured by compression or molding. • It has no meta-stable forms. • Dissolve or disintegrate in the presence of mucous secretions or melt at body temperature ( 360 C) to allow for the release of the medication. 35 Ideal Suppository Base
  • 36. Ideal Suppository Base • Remain molten for a sufficient period of time to allow pouring into moulds. • Solidify sufficiently rapidly to minimize sedimentation of dispersed solids. • Shrink on cooling to allow easy withdrawal of the suppository from the mould. • Has wetting and emulsifying properties. • High water number. • Stable on storage, does not change color, odor and drug release pattern.
  • 37. If the base is fatty, it has the following additional requirements: • Acid value is below 0.2. • Saponification value ranges from 200 to 245. • Iodine value is less than 7. • The interval between melting point and solidification point is small. 37
  • 39. v Theobroma Oil or cocoa butter is used as a suppository base because, in large measure, it fulfills the requirements of an ideal base. v Cocoa butter is primarily a tri-glyceride (Oleopal mitostearin) , it is yellowish- white, solid, brittle fat, which smells and tastes like chocolate. v At ordinary room temperatures of 15° to 25°C it is a hard, amorphous solid, v It melt at 30° to 35°C i.e., at body temperature, it melts to a bland, nonirritating oil. 39
  • 40. v Thus in warm climates, theobroma oil suppositories should be refrigerated. v Cocoa butter has iodine value between 34 and 38. v Its acid value not higher than 4. 40
  • 41. q Shrinks only slightly on solidification; a mould lubricant is therefore required. q Exists in four polymorphic forms with different melting points q Alfa 24 q Beta' 28-31 q Beta (stable) 34-35 (beta' sloly changes to beta stable) q Gamma 18 q Theobroma should only be heated for a short time and at temperatures just below 36 ºC in order to minimize the formation of the unstable low melting point forms. 41
  • 42. q Theobroma oil is prone to oxidation (due to high iodine value); this can be partly overcome by storage in a cool, dark place. q Theobroma oil may vary in consistency, odor, and color depending on its source like other natural products. q The low melting point of theobroma oil may pose storage problems in hot climates. 42
  • 43. How formation of unstable form of polymorphs can be avoided? • If mass is not completly melted, remaining crystal prevent formation of unstable crystal. • Seeding • Solidified mass is tempered at 280-320 C to convert Beta'--> Beta Stable. • Prolonged heating and overheating must be avoided.
  • 44. Additives • Wax/Spermaceti added to keep melting point at 35 when drug used is volatile which can redduce melting point. • Emulsifier to increase water holding capicity.
  • 45. q The change (reduction) in melting point caused by addition of certain drugs such as volatile oils, phenol or chloral hydrate to cocoa butter suppositories. The remedy is to raise the melting point back to the desired range by addition of 3% to 5% of beeswax or spermaceti. q Theobroma oil has a low absorptive capacity for water, but this can be increased by adding surfactants such as cholesterol 2%, emulsifying wax up to 10%, polysorbates 5 to 10%, or wool fat 5 to 10%. However, the addition of surfactants may lead to a drug- base interaction or affect the release of drug from suppository. 45 Additives contd...
  • 46. Substitutes of cocabutter • Synthetic triglycerides • Palm kernel oil • Hydrogenated corn oil
  • 47. q The newer synthetic tri-glycerides consist of esterified, hydrogenated or fractionated vegetable oils. q Their advantages over cocoa butter are: 1- Do not exhibit polymorphism. 2- Contain mainly saturated acids (Iodine number <3), while cocoa butter contains considerable amount of the unsaturated fatty acids (Iodine number 34-38). 47
  • 48. 3- The melting range of the synthetic bases is usually about 3ºC higher than that of cocoa butter 4- The acid content is lower (mostly <0.5) 5- hard fat is a mixture of mono, di and tri- glycerides of saturated fatty acids (C10 to C18). The hydroxyl value of a base is determined by the proportions of mono and di-glycerides contained in it. A higher hydroxyl value indicates that the base can absorb water more readily and less suitable to easily hydrolyzed drugs. 48
  • 49. 6- The solidification temperatures of hard fats are unaffected by over heating. 7- There is only a small temperature difference between melting and solidification, thus the sedimentation of suspended drugs is minimized. 8- The water absorbing capacity of hard fats can be improved (to about 25% or 30% w/w) by inclusion of glyceryl monostearate. 49
  • 50. q A tendency to fracture upon pouring into chilled moulds can be overcome by including very small quantities of polysorbate 80. q On prolonged storage, synthetic suppository bases have been shown to be subjected to crystallization, which causes hardening and increases the melting time. This can be reduced by storage in a cold place. 50
  • 51. A. Glycerinated gelatin B. Polyethylene glycol (PEG) polymers. 51 Hydrophilic suppositories base
  • 52. v Glycerinated Gelatin is a useful suppository base, particularly for vaginal suppositories, where the prolonged localized action is usually desired. v Glycerinated gelatin suppositories are translucent, resilient, gelatinous solids that tend to dissolve in mucous secretions to provide prolonged release of active ingredients. v It is suitable for use with a wide range of medicaments including alkaloids, boric acid, and zinc oxide. 52
  • 53. v Suppositories made with glycerinated gelatin must be kept in well-closed containers in a cool place since they will absorb and dissolve in atmospheric moisture. v Suppositories may have a dehydrating effect and be irritating to the tissues upon insertion. v The water present in the formula of suppositories minimizes this action and the suppositories may be moistened with water prior to insertion to reduce the tendency of the base to draw water from mucous. 53 Contd...Contd...
  • 54. • Mix or dissolve the medicaments in water to make a total of 10 g. • Add 70 g of glycerin and mix. • Add 20 g of granular gelatin, mix carefully to avoid incorporation of air. • Heat on a steam bath until the gelatin is dissolved. • Pour the melted mixture into molds and allow to congeal. 54
  • 55. • The gelatin constitutes about 60% of the weight of the formula, the glycerin about 20%, and the medicated aqueous portion about 20%. 55
  • 56. q Polyethylene Glycol Polymers are chemically stable, nonirritating, miscible with water and mucous secretions, and can be formulated, either by molding or compression, in a wide range of hardness and melting point. 56
  • 57. q Like glycerinated gelatin, they do not melt at body temperature, but dissolve to provide a more prolonged release than theobroma oil. q Certain polyethylene glycol polymers may be used singly as suppository bases q Some times more molecular weights PEG mixed in various proportions as needed to yield a finished product of satisfactory hardness and dissolution time. 57 PEG Contd...PEG Contd...
  • 58. q PEGs having average molecular weights of 200, 400 and 600 are clear, colorless liquids. q Those having molecular weights of greater than 1000 are wax-like, white solids with hardness increasing with an increase in the molecular weight. q Since the water miscible suppositories dissolve in body fluids and need not be formulated to melt at body temperature, they can be formulated with much higher melting points. 58 PEG Contd...PEG Contd...
  • 59. q This property permits a slower release of medicaments from the base, safe storage at room temperature without need for refrigeration, and ease and slow insertion. q To prevent irritation of the mucous membranes after insertion of PEGs suppositories, they should contain at least 20% of water or dipped in water just prior to use. 59 PEG Contd...PEG Contd...
  • 61. • Chemical or physical Mixtures of oleaginous and water soluble or water miscible materials. • Emulsions, generally of w/o type (i.e. mixing of cocoa butter with emulsifying agents). • Polyoxyl 40 stearate is a mixture of the mono- stearate and di-stearate esters of mixed poly- oxyethylene diols and the free glycols. • Soap may be used as a base (i.e. Glycerin suppositories, USP, with soap as the base). 61
  • 62. Suppositories can be extemporaneously prepared by one of three methods. 1. Hand Rolling • It is the oldest and simplest method of suppository preparation and may be used when only a few suppositories are to be prepared in a cocoa butter base. • It has the advantage of avoiding the necessity of heating the cocoa butter. • A plastic-like mass is prepared by triturating grated (pulverized) cocoa butter and active ingredients in a mortar. 62
  • 63. • The mass is formed into a ball in the palm of the hands, then rolled into a uniform cylinder with a large spatula or small flat board on a pill tile. • The cylinder is then cut into the appropriate number of pieces which are rolled on one end to produce a conical shape. • Effective hand rolling requires considerable practice and skill. 63
  • 64. • Compression molding is a method of preparing suppositories from a mixed mass of grated suppository base and medicaments which is forced into a special compression mold using suppository making machines. • The suppository base and the other ingredients are combined by thorough mixing. • The friction of the process causing the base to soften into a past-like consistency. 64
  • 65. • On large scale, mechanically operated mixers and a warmed mixing vessels are used. • In the compression machine, the suppository mass is placed into a cylinder which is then closed. • Pressure is applied from one end to release the mass from the other end into the suppository mold or die. 65 Contd...Contd...
  • 66. Compression molding machine • Prepared mass C is placed in a cylinder A • It is forced through narrow opening D by means of piston B into a mould. • Threads of mass pass in the mould G and are compressed until a homogenous fused mass is formed in E. • The mass and compression cylinder of the machine may be chilled to prevent heat of compression from making the mass too fluid.
  • 67. • When the die is filled with the mass, a movable end 'plate-F' at the back of the die is removed • Additional pressure is applied to eject suppository 67 Contd...Contd...
  • 68. • Fusion Molding involves: 1- Melting the suppository base 2- Dispersing or dissolving the drug in the melted base. 3- The mixture is removed from the heat and poured into a suppository mold. 4- Allowing the melt to congeal 5- Removing the formed suppositories from the mold. • The fusion method can be used with all types of suppositories and must be used with most of them. 68
  • 70. • Small scale molds are capable of producing 6 or 12 suppositories in a single operation. • Industrial molds produce hundreds of suppositories from a single molding. 70
  • 71. • Depending on the formulation, suppository molds may require lubrication before the melt is poured to facilitate the clean and easy removal of the molded suppository. • Lubrication is seldom necessary when the suppository base is contracting sufficiently on cooling. • Lubrication is usually necessary when glycerinated gelatin suppositories are prepared. 71
  • 72. Automatic moulding machine • it can make 10000 unit/hr
  • 73. Formulation concideration • For local use / Systematic use? • Site of application, rectal/vaginal/urethral? • Quick release/ prolonged release?
  • 74. Suppositories for systemic effect 1. Should have sufficient absorption from particular body cavity (if for systemic use) 2. Best suited for drugs undergoing first pass metabolism, degrade in GI fluids or irritate the GI mucosa 3. Should be easily dispersible or soluble in the base 4. Should be soluble to achieve homogeneity but should not have more affinity for the base or else it wouldn't get released 5.Particle size should be less to improve bioavailability and decrease irritation 6. Density and solubility of the drug should ensure minimum usage of base. 7. Drug should be compatible and stable in base and at processing conditions 8. Water soluble drug added in oil soluble base and vice versa
  • 75. Contd... • Suppositories for Local effect – Nonabsorbable drug – Nonabsorbable base – Slow melting base – Should melt within 4-6 hour
  • 76. Problems in formulation of suppositories • Water in Suppositories • Hygroscopicity • Incompatibilities • Viscosity • Brittelness • Density • Volume contraction • Lubrication • Dose replacement • Wt. and volume control • Rancidity/antioxidant
  • 77. 1. Water in suppositories Formulators do not like to use water for dissolving drugs in suppositories for the following reasons : a) Water causes hydrolysis of fats. b) If the suppositories are manufactured at a high temperature, the water evaporates, the drugs crystallize out. c) Absorption of water soluble drugs is enhanced only if the base is an oil – in – water emulsion d) And more than 50% of the water should be in the external phase. e) Drug excipient interactions are more likely to happen in the presence of water. f) Bacterial contamination may be a problem, so we may be forced to add a preservative.
  • 78. 2. Hygroscopicity • Glycerogelatin suppositories lose moisture in dry climates and absorb moisture in humid conditions • The hygroscopicity of polyethylene glycol bases depends on the chain length of the molecule • As the molecular weight of these ethylene oxide polymers increases the hygroscopicity decreases
  • 79. 3. Drug-excipient interactions • Incompatibilities exist between polyethylene glycol base and some drugs eg. quinine. • Sodium barbital and salicylic acid crystallize out of polyethylene glycol. • High concentrations of salicylic acid soften polyethylene glycol to an ointment like consistency. • Penicillin G is stable in cocoa butter and other fatty bases but decomposes in polyethylene glycol bases.
  • 80. 4. Viscosity • When the base has low viscosity, sedimentation of the drug before solidification is a problem. • Well mixed mass should be handelled at lowest possible temperature. • 2% aluminium monostearate may be added to increase the viscosity of the base • Cetyl and stearyl alcohols or stearic acid are added to improve the consistency of suppositories
  • 81. 5. Brittleness • Cocoa butter suppositories are elastic, not brittle • Synthetic fat bases are brittle • This problem can be overcome by keeping the temperature difference between the melted base and the mold as small as possible • Materials that impart plasticity to a fat and make them less brittle are small amounts of Tween 80, castor oil, glycerin or propylene glycol
  • 82. 6. Density • Density of the base, the drug, the volume of the mould and whether the base is having the property of volume contraction are all important. • They all determine the weight of the suppository
  • 83. 7. Volume contraction • Because of volume contraction suppositoray esily slip away from the mould, preventing the need for a lubricating agent. • When the suppository mass is contracting, a hole forms at the open end, This gives an inelegant appearance to the suppository. Weight variation among suppositories is also likely to occur. • To avoid this problem of volume contraction • Overfill the molds, and scrape off the excess mass which contains the contraction hole • Pour the suppository mass slightly above its congealing temperature into a mould warmed to about the same temperature.
  • 84. Displacement value • The displacement value is defined as the number of gram of ingredients (or Drug) that displace one gram of Suppository base • The volume of suppositories from a particular mould will be constant but the weight will vary because the densities of the medicaments usually differ from the density of the base, and hence the density of the medicament will affect the amount of the base required for each suppository • f=[100(E-G)/GX]+1 f=replacement factor E= wt of pure base suppository G= wt of suppository withh X% of drug
  • 85. Example 1 If a prescription requires 400 mg of bismuth subgallate per suppository weighing two grams, what would be the displacement value if it is known that six suppositories with required bismuth subgallate weigh 13.6 g? Theoretical weight of six cocoa butter suppositories without bismuth subgallate = 12 g Given weight of six cocoa butter suppositories with bismuth subgallate =13.6 g Wt. of bismuth subgallate in the six suppositories = 0.4 × 6 = 2.4 g Wt. of cocoa butter in the bismuth subgallate suppositories = 13.6 − 2.4 = 11.2 g Cocoa butter displaced by 2.4 g of bismuth subgallate = 12 − 11.2 = 0.8 The displacement value of bismuth subgallate is 2.4/0.8 = 3
  • 86. Example 2 • If 12 cocoa butter suppositories containing 40% zinc oxide weigh 17.6 grams,what is the displacement value of zinc oxide? Assume that the suppositories are made in a 1-g mold • Given weight of 12 suppositories with zinc oxide = 17.6 grams • Weight of zinc oxide in the suppositories = (40/100) × 17.6 = 7.04 g • Weight of cocoa butter in the suppositories = (60/100) × 17.6 = 10.56 g • Theoretical weight of 12 suppositories without zinc oxide = 12 g • Cocoa butter displaced by 7.04 g of zinc oxide = 12 − 10.56 = 1.44 • Displacement value of zinc oxide = (7.04/1.44) = 4.89
  • 87. 9. Weight and volume control Various factors influence the weight of the suppository, the volume of the suppository and the amount of active ingredient in each suppository are-- 1. Concentration of the drug in the mass 2. Volume of the mould cavity 3. The specific gravity of the base 4. Volume variation between moulds 5. Weight variation between suppositories due to the inconsistencies in the manufacturing process, The limit for the weight variation in suppositories is 5%.
  • 88. 10. Lubrication of moulds • Some widely used lubricating agents are mineral oil, aqueous solution of SLS, alcohol and tincture of green soap. These are applied by wiping, brushing or spraying
  • 89. 11. Rancidity • The unsaturated fatty acids in the suppository bases undergo autooxidation and decompose into aldehydes, ketones and acids. These products have strong, unpleasant odours • The lower the content of unsaturated fatty acids in a base, the higher is its resistance to rancidity
  • 90. EVALUATION OF SUPPOSITORIES Finished suppositories are routinely inspected for; appearance & content uniformity beside this-- • Melting range test/micromelting range • Softning time (U tube water bath & glass rod) • Drug release test • Breaking test (Fragility test) • Disintegration test
  • 91. • Macro-melting range is a measure of the time it takes for the entire suppository to melt when immersed in a constant-temperature (37ºC) water bath.USP tablet disintegration apparatus is used • Micromelting range for fat base using capilllary tubes • ERWEKA® apparatus consist spiral tube with thermostat water jacket. 91
  • 92. Softening time • In this test a U tube is partially immersed in a constant temperature bath and is maintained at a temperature between 35 to 37°C. • There is a constriction in the tube in which the suppository is kept • and above the suppository, a glass rod is kept. • The time taken for the glass rod to go through the suppository and reach the constriction is known as or softening time. • Another apparatus is there for finding “softening time” which mimics in vivo conditions. • It uses a cellophane tube, and the temperature is maintained by water circulation. Time taken for the suppository to melt is noted
  • 93.
  • 94. Breaking test • To measure the fragility or brittleness of suppository • Double wall chamber in which the test suppository is placed. • Water at 37ºC is pumped through the double wall. • The suppository supports a disc to which rod is attached. • The other end of the rod consist of another disc to which weights are applied. 94
  • 95. • The test was conducted by placing the suppository to support the axis of 600 g weight. • At one minute intervals 200 gm weights are added. • The weight at which the suppository collapses is the breaking point • Different shape suppositories have different value of hardness. 95 Breaking test
  • 96. Dissolution/Disintegration test • In-vitro drug release pattern is measured by using ERWEKA® Disintegration apparatus • Aliquots of the release medium were taken at different time intervals within the melting period. • The drug content in the aliquots was determined using UV • The drug release pattern was plotted (time versus-drug release curve)
  • 98. Packaging • Aluminium foil • Paper wrap • in-package moulding
  • 99. Packaging of suppositories • They should not touch each other, otherwise they may fuse togther • Proper wrapinng with aluminium foil, or paper is required • Machine packaging avoid nonuniformity – after solidification wraping – sealing using two halves of plastic • In package moulding – Top of package mould remain open, after mass injected it is sealed – High production rate – At high temperature shape is retained
  • 100. Packaging, labelling & Storage for suppositories Rigid paperboard boxes Flat box with a lid Labelling : 1. Store in a cool place 2. For rectal use only 3. Moisten before use (for glycero-gelatin and macrogol bases)